At Gibson Oncology, we are dedicated to providing crucial updates regarding our advancements in brain cancer treatment, including our NIH-sponsored phase II trial in Glioblastoma patients who have failed their initial drug. We encourage you to reach out with any questions or comments regarding our research initiatives.